Dr. Marie McNeely

Dysfunction in the homeostasis of iron and other elements likely contributes to the development of Parkinson's disease (PD), and Dr. Paul Lingor is working to identify patterns of bioelements in CSF that could be used as biomarkers. He is also studying tear fluid as a potential biomarker source and is involved in studying PD therapies, including the drug Fasudil as well as combinations of advanced therapies for people with later-stage PD. Learn more about his work in our latest podcast episode!

michaeljfox.org/podcast/episod

#Parkinsons #ParkinsonsDisease #ParkinsonsResearch #Neuroscience #Neurology #Biomarkers #Biomarker #Diagnostics #ClinicalTrials #AdvancedTherapies #Research #MJFF

Dr Marguerite Evans-Galea AM

NSW Health, Australia, has set a national benchmark for standardising the preparation of pharmaceuticals and advanced therapeutic products with a new Policy Directive that outlines new and updated state-wide approaches.

Learn more about the Directive & author Kerry Watts: medicalresearch.nsw.gov.au/fut #AdvancedTherapies #CellTherapies #GeneTherapies

Lluis Montoliu

3rd ARRIGE Albrecht Müller Seminar (free online conference) on ‘Human Therapeutic Applications of Gene Editing’ November 13th, 2023 – 2pm-5pm (CET) – Paris time.
#CRISPR #GenomeEditing #ClinicalTrials #BaseEditing #primeediting #crisprcas9 #genetherapy #advancedtherapies #ARRIGE #ResponsibleResearch #ethics #bioethics #rri #innovation
Full information and registrarion link to gain free access to this meeting available at:
arrige.org/portfolio/3rd-albre

Innovative Health Initiative

IMI project ARDAT @AAtmps@twitter.com is working to deliver the knowledge, tools and standards needed to speed up the development of #AdvancedTherapies, focusing on #RareDiseases caused by a single gene mutation.
➡️bit.ly/3Z5BeRy
#RareDiseaseDay

Accelerating research & development for advanced therapies

Advanced therapy medicinal products (ATMPs) such as…

bit.ly
Innovative Health Initiative

Interested in our new call topic on #AdvancedTherapies and #RareDiseases?
The #IHICallDays info session on the topic is today (13/12) at 13:00 CET.
Sign up at bit.ly/IHICallDays3
Get the details on the call at bit.ly/IHIcall3
#HorizonEU